Literature DB >> 34141648

A Case Report of Chondromyxoid Fibroma of the Neck of Femur, Intracapsular Location.

Siddharth Jain1, Sitender Garg1, Ravi Mittal1.   

Abstract

INTRODUCTION: Chondromyxoid fibroma (CMF) is an uncommon benign tumor accounts for <2% of all benign and <1% all bone tumors. It is a cartilage tumor with myxoid and fibrous elements. Because of rarity and resemblance with other benign and malignant tumor, diagnosis of this tumor always remains challenging. Often, this lesion affects metaphysis of long growing bones of children and young adults. Common locations of this tumor are around the growth plate of proximal tibia and fibula and distal femur. CASE REPORT: A 21-year-old male presented to orthopedic outpatient department with a history of the left hip pain for 1 year, following a trivial fall before 1 year. The patient was not able to do heavy strenuous activities such as running, jumping, and other sports activities. Terminal range of movements were painful. Magnetic resonance imaging suggested of cystic lesion involving synovial lining near head-and-neck junction of the left femur. Curettage of the lesion was done. The bone defect was not found to be large enough to be filled with bone graft. Histopathological examination showed lobular pattern with stellate to spindle-shaped cells on the myxoid background.
CONCLUSION: CMF of subcapital region of femoral neck is an extremely unusual presentation. When occurring in middle-aged persons and in uncommon locations, this can raise suspicion of chondrosarcoma. Although intralesional curettage has the risk of recurrence in post-operative period, sufficient and careful curettage and excision of lesion will be enough to treat these benign lesions with good prognosis. Copyright: © Indian Orthopaedic Research Group.

Entities:  

Keywords:  Chondromyxoid fibroma; benign tumor; intracapsular

Year:  2021        PMID: 34141648      PMCID: PMC8046461          DOI: 10.13107/jocr.2021.v11.i01.1972

Source DB:  PubMed          Journal:  J Orthop Case Rep        ISSN: 2250-0685


  10 in total

1.  Chondromyxoid fibroma of bone, with emphasis on its morphological relationship to benign chondroblastoma.

Authors:  D C DAHLIN
Journal:  Cancer       Date:  1956 Jan-Feb       Impact factor: 6.860

2.  Chondromyxoid fibroma of bone; a distinctive benign tumor likely to be mistaken especially for chondrosarcoma.

Authors:  H L JAFFE; L LICHTENSTEIN
Journal:  Arch Pathol (Chic)       Date:  1948-04

3.  Chondromyxoid fibroma: a clinicopathologic study of 76 cases..

Authors:  A Rahimi; J W Beabout; J C Ivins; D C Dahlin
Journal:  Cancer       Date:  1972-09       Impact factor: 6.860

4.  Chondromyxoid fibroma (fibromyxoid chondroma) of bone. A clinico-pathological study of thirty-two cases.

Authors:  F Schajowicz; H Gallardo
Journal:  J Bone Joint Surg Br       Date:  1971-05

5.  Chondromyxoid fibroma. The experience at the Istituto Ortopedico Rizzoli.

Authors:  F Gherlinzoni; M Rock; P Picci
Journal:  J Bone Joint Surg Am       Date:  1983-02       Impact factor: 5.284

6.  Chondromyxoid fibroma in the metacarpal bone of the thumb.

Authors:  G M Declerck; I D Rawlings; A C Hunt
Journal:  Acta Orthop Belg       Date:  1992       Impact factor: 0.500

Review 7.  Cartilaginous bone tumors.

Authors:  M A Giudici; R P Moser; M J Kransdorf
Journal:  Radiol Clin North Am       Date:  1993-03       Impact factor: 2.303

Review 8.  Subperiosteal chondromyxoid fibroma: a report of two cases.

Authors:  Ryan K Takenaga; Frank J Frassica; Edward F McCarthy
Journal:  Iowa Orthop J       Date:  2007

9.  Chondromyxoid fibroma of bone: thirty-six cases with clinicopathologic correlation.

Authors:  D A Zillmer; H D Dorfman
Journal:  Hum Pathol       Date:  1989-10       Impact factor: 3.466

10.  Chondromyxoid fibroma management: a single institution experience of 22 cases.

Authors:  Jagmeet S Bhamra; Hesham Al-Khateeb; Baljinder S Dhinsa; Panos D Gikas; Roberto Tirabosco; Robin C Pollock; John A Skinner; William J Aston; Asif Saifuddin; Timothy Wr Briggs
Journal:  World J Surg Oncol       Date:  2014-09-12       Impact factor: 2.754

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.